학술논문
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study
Document Type
Article
Author
Source
In: The Lancet Diabetes and Endocrinology . (The Lancet Diabetes and Endocrinology, May 2022, 10(5):341-350)
Subject
Language
English
ISSN
22138595
22138587
22138587